CVE-2022-41967

Improper Restriction of XML External Entity Reference in Dragonfly

Description

Dragonfly is a Java runtime dependency management library. Dragonfly v0.3.0-SNAPSHOT does not configure DocumentBuilderFactory to prevent XML external entity (XXE) attacks. This issue is patched in 0.3.1-SNAPSHOT. As a workaround, since Dragonfly only parses XML `SNAPSHOT` versions are being resolved, this vulnerability may be avoided by not trying to resolve `SNAPSHOT` versions.

Category

7.0
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.02%
Third-Party Advisory github.com Third-Party Advisory github.com
Affected: HyperaDev Dragonfly
Published at:
Updated at:

References

Link Tags
https://github.com/HyperaDev/Dragonfly/security/advisories/GHSA-6x3m-96qp-mmxv third party advisory patch
https://github.com/HyperaDev/Dragonfly/commit/9661375e1135127ca6cdb5712e978bec33cc06b3 third party advisory patch

Frequently Asked Questions

What is the severity of CVE-2022-41967?
CVE-2022-41967 has been scored as a high severity vulnerability.
How to fix CVE-2022-41967?
To fix CVE-2022-41967, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-41967 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-41967 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-41967?
CVE-2022-41967 affects HyperaDev Dragonfly.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.